BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34768927)

  • 1. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
    Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
    Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
    Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
    Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
    Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
    Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
    Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
    Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion
    Papatheodorou I; Makrecka-Kuka M; Kuka J; Liepinsh E; Dambrova M; Lazou A
    Front Endocrinol (Lausanne); 2022; 13():941822. PubMed ID: 36046786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
    Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
    Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells.
    Palomer X; Capdevila-Busquets E; Botteri G; Salvadó L; Barroso E; Davidson MM; Michalik L; Wahli W; Vázquez-Carrera M
    Int J Cardiol; 2014 Jun; 174(1):110-8. PubMed ID: 24767130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
    Ali FY; Hall MG; Desvergne B; Warner TD; Mitchell JA
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1871-3. PubMed ID: 19696401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
    Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation.
    Benedetti E; Di Loreto S; D'Angelo B; Cristiano L; d'Angelo M; Antonosante A; Fidoamore A; Golini R; Cinque B; Cifone MG; Ippoliti R; Giordano A; Cimini A
    J Cell Physiol; 2016 Mar; 231(3):597-606. PubMed ID: 26206209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.
    Toral M; Romero M; Pérez-Vizcaíno F; Duarte J; Jiménez R
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H189-H200. PubMed ID: 27881385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
    Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
    Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.